TickerFacts.

A business in context

IBO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-23 · 0001493152-26-046572 · Items 5.03,9.01

  2. 4 · Ownership change

    Report date 2026-09-22 · 0001493152-26-044207

  3. 8-K · Current report

    Report date 2026-09-16 · 0001493152-26-042975 · Items 7.01,9.01

  4. 8-K · Current report

    Report date 2026-09-14 · 0001493152-26-042635 · Items 7.01,9.01

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001493152-26-036601

  6. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001493152-26-022512

  7. 4 · Ownership change

    Report date 2026-03-25 · 0001493152-26-013708

  8. 4 · Ownership change

    Report date 2026-03-23 · 0001493152-26-012746

  9. 10-K · Annual report

    Report date 2025-12-31 · 0001493152-26-009711

  10. 8-K · Current report

    Report date 2026-02-27 · 0001493152-26-008879 · Items 1.01,9.01

  11. 4 · Ownership change

    Report date 2025-05-22 · 0001493152-26-000635

  12. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001493152-25-021286

  13. 8-K · Current report

    Report date 2025-11-05 · 0001493152-25-021066 · Items 5.07

  14. 8-K · Current report

    Report date 2025-10-24 · 0001493152-25-019734 · Items 8.01

  15. DEF 14A · Proxy statement

    Report date 2025-09-22 · 0001493152-25-014484

  16. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001641172-25-023809

  17. 8-K · Current report

    Report date 2025-07-21 · 0001641172-25-021085 · Items 1.01,9.01

  18. 8-K · Current report

    Report date 2025-06-23 · 0001641172-25-016002 · Items 1.01,7.01,9.01

  19. 4 · Ownership change

    Report date 2025-05-22 · 0001641172-25-012502

  20. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001641172-25-010276

  21. 4 · Ownership change

    Report date 2025-04-04 · 0001641172-25-003114

  22. 4 · Ownership change

    Report date 2025-04-03 · 0001641172-25-003021

  23. 4 · Ownership change

    Report date 2025-04-02 · 0001641172-25-002819

  24. 8-K · Current report

    Report date 2025-04-03 · 0001641172-25-002577 · Items 1.01

  25. 10-K · Annual report

    Report date 2024-12-31 · 0001641172-25-001199

  26. 8-K · Current report

    Report date 2025-03-24 · 0001641172-25-001060 · Items 1.01,9.01

  27. 8-K · Current report

    Report date 2025-03-11 · 0001493152-25-010190 · Items 5.02

  28. 8-K · Current report

    Report date 2025-01-29 · 0001493152-25-004161 · Items 7.01,9.01

  29. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001493152-24-044792

  30. 8-K · Current report

    Report date 2024-11-04 · 0001493152-24-043558 · Items 7.01,9.01

  31. 8-K · Current report

    Report date 2024-10-03 · 0001493152-24-040465 · Items 5.02,9.01

  32. 8-K · Current report

    Report date 2024-09-16 · 0001493152-24-036888 · Items 1.01,8.01,9.01

  33. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001493152-24-031635

  34. 8-K · Current report

    Report date 2024-06-06 · 0001493152-24-023096 · Items 5.02

  35. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001493152-24-018663

  36. 10-K · Annual report

    Report date 2023-12-31 · 0001493152-24-007229

  37. 8-K · Current report

    Report date 2024-01-18 · 0001493152-24-003318 · Items 1.01,9.01

  38. 10-Q · Quarterly report

    Report date 2023-09-30 · 0001493152-23-040547

  39. 8-K · Current report

    Report date 2023-10-31 · 0001493152-23-039584 · Items 1.01,3.03,5.03,8.01,9.01

  40. 10-Q · Quarterly report

    Report date 2023-06-30 · 0001493152-23-036365

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 3 transaction rows3SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

3 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-24
2026-09-24
DSS, INC.S · Sale
Disposed
Common Stock156.07.06
2026-09-23
2026-09-24
DSS, INC.S · Sale
Disposed
Common Stock27.06.95
2026-09-22
2026-09-24
DSS, INC.S · Sale
Disposed
Common Stock723.00.55

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001834105IMPACT BIOMEDICAL INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2022-12-31$50.0K$57.6K

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗